Cellular proteins in HIV virions

Reviews in Medical Virology

Volumn 7, Issue 3, 1997, Pages 167-180

  Ott, David E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYCLOPHILIN A; CYTOSKELETON PROTEIN; HERMES ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UBIQUITIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HLA SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; VACCINATION; VIRION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS INFECTION;

EID: 0030930244     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1654(199709)7:3<167::AID-RMV199>3.0.CO;2-K     Document Type: Review

References (15)

1. Levy, J. A. ed. (1995). The Retroviridae, Vol. 4. Plenum Press, New York.
2. Pantaleo, G. and Fauci, A. S. (1996). Immunopathogenesis of HIV infection. Annu. Rev. Microbiol. 50, 825-854.
3. Varmus, H. and Brown, P. (1989). Retroviruses. In, ed. by D. E. Berg and M. M. House, pp. 53-108.
4. Wain-Hobson, S. (1996). One on one meets two. Nature (London) 384, 117-118.
5. Gelderblom, H. R. (1991). Assembly and morphology of HIV: potential effect of structure on viral function. AIDS 5, 617-638.
6. Kaplan, A. H., Manchester, M. and Swanstrom, R. (1994). The activity of the protease of human immunodeficiency virus type 1 is initated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J. Virol. 68, 6782-6786.
7. Kaplan, A. H. and Swanstrom, R. (1991). HIV-1 gag proteins are processed in two cellular compartments. Proc. Natl Acad. Sci. (USA) 88, 4528-4532.
8. Trono, D. (1995). HIV accessory proteins: leading roles for the supporting cast. Cell 82, 189-192.
9. Subbramanian, R. A. and Cohen, E. A. (1994). Molecular biology of the human immunodeficiency virus accessory proteins. J. Virol. 68, 6831-6835.
10. Arthur, L. O., Bess, J. W. Jr., Sowder, R. C. II et al. (1992). Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258, 1935-1938.
11. Henderson, L. E., Sowder, R. C. II, Copeland, T. D. et al. (1987). Direct identification of class II histocompatibility antigens in preparations of human lymphotropic virus type III. J. Virol. 61, 629-632.
12. Hoxie, J. A., Fitzharris, T. P., Youngbar, P. R., Matthews, D. M. Rackowski, J. L. and Radka, S. F. (1987). Nonrandom association of cellular antigens with HTLV-III virions. Human Immun. 18, 39-52.
13. Bess, J. W. Jr., Gorelick, R. J., Bosche, W. J., Henderson, L. E. and Arthur, L. O. (1997). Microvesicles are a source of contaiminating cellular proteins found in purified HIV-1 preparations. Virology 230, 134-144.
14. Gluschankof, P., Mondor, L, Gelderblom, H. R. and Sattentau, Q. J. (1997). Cell membrane vesicles are a major contaiminant of gradient- enriched human immunodeficiency virus type-1 preparations. Virology 230, 125-133.
15. Zavada, J. (1982). The pseudotypic paradox. J. Gen. Virol. 63, 15-24.